NCT00739206View on ClinicalTrials.gov

Study of SAR97276A in the Treatment of Uncomplicated and Severe Malaria in Adults and Children.

PHASE2TerminatedINTERVENTIONAL
Enrollment

113

Participants

Timeline

Start Date

August 31, 2008

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions
Malaria
Interventions
DRUG

SAR97276A

Dose based on body weight

Trial Locations (4)

Unknown

Sanofi-Aventis Administrative Office, Porto-Novo

Sanofi-Aventis Administrative Office, Ouagadougou

Sanofi-Aventis Administrative Office, Libreville

Sanofi-Aventis Administrative Office, Dodoma

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT00739206 - Study of SAR97276A in the Treatment of Uncomplicated and Severe Malaria in Adults and Children. | Biotech Hunter | Biotech Hunter